Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Becton Dickinson: Fiscal 4Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/05/2019 | 06:22am EST

FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Tuesday reported fiscal fourth-quarter net income of $150 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Franklin Lakes, New Jersey-based company said it had profit of 41 cents. Earnings, adjusted for one-time gains and costs, came to $3.31 per share.

The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $3.30 per share.

The medical device manufacturer posted revenue of $4.58 billion in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $4.57 billion.

For the year, the company reported profit of $1.22 billion, or $3.89 per share. Revenue was reported as $17.29 billion.

Becton Dickinson expects full-year earnings in the range of $12.50 to $12.65 per share.

Becton Dickinson shares have increased 16% since the beginning of the year, while the Standard & Poor's 500 index has risen 23%. The stock has risen 11% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDX at https://www.zacks.com/ap/BDX

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON, DICKINSON AND COMP
01/23BECTON DICKINSON AND : BD Announces Webcast of Annual Meeting of Shareholders
PR
01/17Health Executives Brace for Change In Regulation and Competition -- WSJ
DJ
01/16Health Executives Gear Up for Change at J.P. Morgan Conference
DJ
01/10BECTON DICKINSON AND : LongueVue Capital Adds Experienced Healthcare Operating P..
PR
01/09BECTON DICKINSON AND : BD Announces Live Webcast Of First Fiscal Quarter Earning..
PR
01/06BECTON, DICKINSON AND COMPANY : Report
CO
01/03BECTON DICKINSON AND : BD to Present at the 38th Annual J.P. Morgan Healthcare C..
PR
01/03BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
More news
Financials (USD)
Sales 2020 18 038 M
EBIT 2020 4 805 M
Net income 2020 2 435 M
Debt 2020 15 093 M
Yield 2020 1,26%
P/E ratio 2020 28,2x
P/E ratio 2021 24,2x
EV / Sales2020 5,04x
EV / Sales2021 4,66x
Capitalization 75 816 M
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 286,41  $
Last Close Price 279,75  $
Spread / Highest target 12,6%
Spread / Average Target 2,38%
Spread / Lowest Target -8,85%
EPS Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman & Chief Executive Officer
Thomas E. Polen President & Chief Operating Officer
Christopher R. Reidy Chief Financial Officer, CAO & EVP-Administration
John A. DeFord Chief Technology Officer & Executive VP
William R. Sigmund Chief Medical Officer & EVP
Sector and Competitors